Covid-19: The daily dose (June 16, 2021)

Our Bureau Mumbai | Updated on June 16, 2021

We curate for you all the Covid-19-related developments and stories of the day worth reading.

# Bharat Biotech makes a strong pitch for revised procurement prices on Covid-19 vaccines. A detailed explanation from the company on why they price their vaccine the way they do.

# For the first time, the Government confirms one death, due to an adverse event following immunisation (AEFI). But, they add, deaths stand at 0.0002% of 23.5 crore doses administered.

# A new virus variant now put on watch, says the Centre in its routine briefing.

# In a mixed bag of developments, as the UK pushes back its unlock plans due to the Delta variant, UK-based AstraZeneca says its vaccine protects against the Delta variant (that originated in India); but also reports a setback from its monoclonal antibody trials.

# Thermo Fisher brings out point-of-care RT-PCR tests, as States begin to unlock.

# Dosing gap between vaccines increased, without NTAGI scientists agreeing entirely, says a report.

# And watch out for that Oximeter app, you could find yourself in other trouble involving your data.

Published on June 16, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like